The monitors, which track blood sugar levels, have historically been approved solely for diabetic patients since 1999.
The OTC approval affects not only the approximately 38 million Americans with diabetes but the 97.6 million who are prediabetic and people who want to track their blood sugar. On Reddit, users are promoting the devices for weight loss and exercise tracking; and on a broader scale, the monitors could accelerate earlier diabetes diagnoses, according to the report.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
